Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-09

Clinical Trial Update: A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome [Phase 3]

View source ↗

Summary

Phase 3 study evaluating teduglutide in Chinese adults with Short Bowel Syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teduglutide (teduglutide)

Snippet

Sponsor: Takeda | Conditions: Short Bowel Syndrome | Phase 3 | Status: RECRUITING